Status:
UNKNOWN
New Markers of Glycation to Predict Gestational Diabetes Mellitus and Macrosomia.
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Société Francophone du Diabète
Conditions:
Macrosomia, Fetal
Gestational Diabetes Mellitus in Pregnancy
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
Gestational diabetes mellitus (GDM) increases the risk of macrosomia and other adverse pregnancy outcomes. Screening strategies are debated: universal vs. selective, and macrosomia may begin before th...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Age ≥ 18 years
- Singleton pregnancy (or twin pregnancy reduced spontaneously or medically before 14 weeks of amenorrhea)
- Gestational age at inclusion \<28 weeks of amenorrhea
- Participant affiliated with or beneficiary of a social security scheme
- Collection of patient consent.
- Exclusion criteria:
- Gestational age at inclusion ≥ 28 weeks of amenorrhea
- Multiple pregnancy
- Known diabetes prior to pregnancy
- History of bariatric surgery
- Expected delivery in another maternity unit not participating in the study
- Person deprived of liberty by judicial or administrative decision
- Guardianship or curatorship
- Participant not affiliated or not benefiting from a social security scheme.
Exclusion
Key Trial Info
Start Date :
December 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06048510
Start Date
December 18 2023
End Date
April 1 2025
Last Update
December 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Pellegrin
Bordeaux, France, 33000